Hep-Art is managed by Robert Chamuleau (CSO).
Robert A.F.M. Chamuleau, MD, PhD (CSO)

Dr. Chamuleau, is a retired hepatologist at the Academic Medical Center Amsterdam and an associate professor at the University of Amsterdam. He supervised the development of the AMC-BAL and is responsible for the current R&D as well as the coordination of the clinical trial. Dr. Chamuleau is recognized as a leading scientist in the field of bio-artificial liver devices and has a strong international network.